359 related articles for article (PubMed ID: 30354010)
1. Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.
Gustafsson C; Persson E; Gunnlaugsson A; Olsson LE
J Appl Clin Med Phys; 2018 Nov; 19(6):185-192. PubMed ID: 30354010
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images.
Persson E; Emin S; Scherman J; Jamtheim Gustafsson C; Brynolfsson P; Ceberg S; Gunnlaugsson A; Olsson LE
Radiat Oncol; 2021 Aug; 16(1):150. PubMed ID: 34399806
[TBL] [Abstract][Full Text] [Related]
3. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy.
Gustafsson C; Korhonen J; Persson E; Gunnlaugsson A; Nyholm T; Olsson LE
Med Phys; 2017 Nov; 44(11):5563-5574. PubMed ID: 28803447
[TBL] [Abstract][Full Text] [Related]
4. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
Pathmanathan AU; Schmidt MA; Brand DH; Kousi E; van As NJ; Tree AC
J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
[TBL] [Abstract][Full Text] [Related]
5. MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria.
Persson E; Jamtheim Gustafsson C; Ambolt P; Engelholm S; Ceberg S; Bäck S; Olsson LE; Gunnlaugsson A
Radiat Oncol; 2020 Apr; 15(1):77. PubMed ID: 32272943
[TBL] [Abstract][Full Text] [Related]
6. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
Ghose S; Mitra J; Rivest-Hénault D; Fazlollahi A; Stanwell P; Pichler P; Sun J; Fripp J; Greer PB; Dowling JA
Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
[TBL] [Abstract][Full Text] [Related]
7. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
Tanaka O; Komeda H; Iida T; Tamaki M; Seike K; Kato D; Hirose S; Kawaguchi D; Yokoyama T
Radiol Med; 2017 Mar; 122(3):204-207. PubMed ID: 27981486
[TBL] [Abstract][Full Text] [Related]
8. Validation of a deformable MRI to CT registration algorithm employing same day planning MRI for surrogate analysis.
Padgett KR; Stoyanova R; Pirozzi S; Johnson P; Piper J; Dogan N; Pollack A
J Appl Clin Med Phys; 2018 Mar; 19(2):258-264. PubMed ID: 29476603
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of a deep learning based artificial intelligence for automatic identification of gold fiducial markers in an MRI-only prostate radiotherapy workflow.
Gustafsson CJ; Swärd J; Adalbjörnsson SI; Jakobsson A; Olsson LE
Phys Med Biol; 2020 Nov; 65(22):225011. PubMed ID: 33179610
[TBL] [Abstract][Full Text] [Related]
11. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150
[TBL] [Abstract][Full Text] [Related]
12. Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.
Tanaka O; Komeda H; Hirose S; Taniguchi T; Ono K; Matsuo M
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e405-e411. PubMed ID: 29193796
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers.
Goudschaal K; Beeksma F; Boon M; Bijveld M; Visser J; Hinnen K; van Kesteren Z
Radiat Oncol; 2021 Feb; 16(1):37. PubMed ID: 33608008
[TBL] [Abstract][Full Text] [Related]
15. Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement.
Knybel L; Cvek J; Blazek T; Binarova A; Parackova T; Resova K
Radiat Oncol; 2021 Dec; 16(1):235. PubMed ID: 34876173
[TBL] [Abstract][Full Text] [Related]
16. A generative adversarial network-based (GAN-based) architecture for automatic fiducial marker detection in prostate MRI-only radiotherapy simulation images.
Singhrao K; Fu J; Parikh NR; Mikaeilian AG; Ruan D; Kishan AU; Lewis JH
Med Phys; 2020 Dec; 47(12):6405-6413. PubMed ID: 32989773
[TBL] [Abstract][Full Text] [Related]
17. Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
Jonsson JH; Garpebring A; Karlsson MG; Nyholm T
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1612-8. PubMed ID: 21477942
[TBL] [Abstract][Full Text] [Related]
18. Cone beam CT for QA of synthetic CT in MRI only for prostate patients.
Palmér E; Persson E; Ambolt P; Gustafsson C; Gunnlaugsson A; Olsson LE
J Appl Clin Med Phys; 2018 Nov; 19(6):44-52. PubMed ID: 30182461
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
20. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
van Lin EN; Fütterer JJ; Heijmink SW; van der Vight LP; Hoffmann AL; van Kollenburg P; Huisman HJ; Scheenen TW; Witjes JA; Leer JW; Barentsz JO; Visser AG
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):291-303. PubMed ID: 16618584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]